Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands. [electronic resource]
Producer: 20171215Description: 6381-6387 p. digitalISSN:- 1873-2518
- Adult
- Aged
- Aged, 80 and over
- Cohort Studies
- Cost-Benefit Analysis
- Female
- Human papillomavirus 16 -- isolation & purification
- Human papillomavirus 18 -- isolation & purification
- Humans
- Middle Aged
- Models, Statistical
- Netherlands -- epidemiology
- Papillomavirus Infections -- economics
- Papillomavirus Vaccines -- administration & dosage
- Quality-Adjusted Life Years
- Uterine Cervical Dysplasia -- economics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.